Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.

Saved in:
Bibliographic Details
Title: Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Authors: Pasello, Giulia1,2 (AUTHOR) giulia.pasello@iov.veneto.it, Fabricio, Aline S. C.1 (AUTHOR), Del Bianco, Paola3 (AUTHOR), Salizzato, Valentina1 (AUTHOR) valentina.salizzato@iov.veneto.it, Favaretto, Adolfo4 (AUTHOR), Piccin, Luisa1 (AUTHOR), Zustovich, Fable5 (AUTHOR), Fabozzi, Alessio6 (AUTHOR), De Rossi, Costanza7 (AUTHOR), Pigozzo, Jacopo1 (AUTHOR), De Nuzzo, Mattia1,2 (AUTHOR), Cappelletto, Elia8 (AUTHOR), Bonanno, Laura1 (AUTHOR), Palleschi, Dario4 (AUTHOR), De Salvo, Gian Luca3 (AUTHOR), Guarneri, Valentina1,2 (AUTHOR), Gion, Massimo8 (AUTHOR), Chiarion-Sileni, Vanna1 (AUTHOR)
Source: Journal of Translational Medicine. 3/5/2024, Vol. 22 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-024-04920-6